We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
+5.01%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$1.71B
AUM Growth
+$31.6M
Cap. Flow
-$34.4M
Cap. Flow %
-2.01%
Top 10 Hldgs %
32.57%
Holding
586
New
76
Increased
162
Reduced
181
Closed
60

Sector Composition

Rank Sector Weight
1 Technology 15.28%
2 Healthcare 6.75%
3 Financials 6.23%
4 Communication Services 5.69%
5 Industrials 4.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJK icon
401
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
$447K 0.03%
7,672
+100
+1% +$5.81K
ARRS
402
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$441K 0.03%
16,975
RTEC
403
DELISTED
Rudolph Technologies Inc
RTEC
$435K 0.03%
17,800
-7,200
-29% -$198K
ASB icon
404
Associated Banc-Corp
ASB
$5.72B
$434K 0.03%
16,700
VOO icon
405
Vanguard S&P 500 ETF
VOO
$967B
$434K 0.03%
1,626
+655
+67% +$171K
SAH icon
406
Sonic Automotive
SAH
$3.13B
$432K 0.03%
+22,300
New +$461K
ARRY
407
DELISTED
Array Biopharma Inc
ARRY
$429K 0.03%
28,200
ESIO
408
DELISTED
Electro Scientific Industries
ESIO
$429K 0.03%
24,600
-11,800
-32% -$230K
CAT icon
409
Caterpillar
CAT
$412B
$428K 0.03%
2,807
+195
+7% +$27.6K
SLM icon
410
SLM Corp
SLM
$4.56B
$428K 0.03%
38,400
STC icon
411
Stewart Information Services
STC
$1.95B
$428K 0.03%
9,500
CNO icon
412
CNO Financial Group
CNO
$4.91B
$427K 0.03%
20,100
VRTX icon
413
Vertex Pharmaceuticals
VRTX
$120B
$424K 0.02%
2,200
ATKR icon
414
Atkore
ATKR
$2.47B
$422K 0.02%
15,900
-15,200
-49% -$380K
ESGR
415
DELISTED
Enstar Group
ESGR
$417K 0.02%
2,000
SDY icon
416
State Street SPDR S&P Dividend ETF
SDY
$21.6B
$417K 0.02%
4,261
-200
-4% -$19.4K
SPSB icon
417
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
$417K 0.02%
13,805
-7,420
-35% -$224K
VYGR icon
418
Voyager Therapeutics
VYGR
$187M
$416K 0.02%
22,000
SCHG icon
419
Schwab US Large-Cap Growth ETF
SCHG
$58.4B
$412K 0.02%
40,160
-640
-2% -$6.38K
CUZ icon
420
Cousins Properties
CUZ
$5.19B
$404K 0.02%
11,350
-6,400
-36% -$238K
TSQ icon
421
Townsquare Media
TSQ
$115M
$404K 0.02%
+51,624
New +$406K
AERI
422
DELISTED
Aerie Pharmaceuticals
AERI
$400K 0.02%
6,500
ESPR
423
DELISTED
Esperion Therapeutics
ESPR
$399K 0.02%
9,000
ARE icon
424
Alexandria Real Estate Equities
ARE
$8.73B
$397K 0.02%
3,160
PTVCB
425
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
$397K 0.02%
17,300

Similar funds

Bailard's Q3 2018 Portfolio in Review

As of Q3 2018, Bailard held 586 positions worth $1.71B, up 1.9% from $1.68B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Bailard's Q3 2018 filing shows 76 new, 162 increased, 181 reduced and 60 closed positions. Its largest new stake was Teva Pharmaceuticals: 369,700 shares worth $7.96M. The largest sale was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $58.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Bailard's largest Q3 2018 buy was Teva Pharmaceuticals: 369,700 shares worth $7.96M.
  • Bailard added most to iShares Russell 2000 Value ETF in Q3 2018, an estimated $58.4M increase.
  • Bailard's biggest Q3 2018 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $58.9M.
  • Bailard fully exited Mercado Libre in Q3 2018, selling an estimated $3.89M.
  • Bailard's ten largest holdings make up 33% of its $1.71B portfolio in Q3 2018.
  • Bailard opened 76 new positions and closed 60 in Q3 2018.
  • Bailard's portfolio value rose 1.9% quarter-over-quarter to $1.71B.

Based on Bailard's 13F filing for Q3 2018, filed 13 Nov 2018.